Indegene (NSE:INDGN) Marketable Securities: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:INDGN Indegene Ltd NSE:INDGN
50 GF Score
Price ₹601.50
! 8 Warning Signs
View Full Analysis

What is Indegene Marketable Securities?

Indegene NSE:INDGN +0.22% 50 Marketable Securities is ₹0 Mil as of Jun. 2026. GuruFocus rates NSE:INDGN with a GF Score™ of 50/100. The stock has 8 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Indegene's Marketable Securities for the quarter that ended in Jun. 2026 was ₹0 Mil.

Indegene's annual Marketable Securities increased from Mar. 2024 (₹8,288 Mil) to Mar. 2025 (₹14,233 Mil) but then declined from Mar. 2025 (₹14,233 Mil) to Mar. 2026 (₹11,806 Mil).

Indegene  (NSE:INDGN) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Indegene Marketable Securities Related Terms

Indegene Marketable Securities Historical Data

* Premium members only.

The historical data trend for Indegene's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Indegene Marketable Securities Chart

Indegene Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Marketable Securities
Get a 7-Day Free Trial 1,200.00 6,377.56 8,288.00 14,233.00 11,806.00

Indegene Quarterly Data
Mar21 Mar22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 9,026.00 0.00 11,806.00 0.00
NSE:INDGN
50GF Score
Indegene Ltd NSE:INDGN
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Indegene Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ₹0 Mil mean?
Indegene (NSE:INDGN) has a Marketable Securities of ₹0 Mil as of Jun. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Indegene and its competitors.
Is Indegene's Marketable Securities too high?
Indegene's current Marketable Securities is ₹0 Mil. Overall, Indegene has a GF Score™ of 50/100, reflecting its overall financial health beyond just this single metric.
How does Indegene's Marketable Securities compare to VEEV and BTSG?
Indegene's Marketable Securities of ₹0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Healthcare Providers & Services company?
A good Marketable Securities depends on the Healthcare Providers & Services industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Indegene and its competitors. Indegene's current Marketable Securities is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indegene stock overvalued right now?
Indegene (NSE:INDGN) has a current Marketable Securities of ₹0 Mil. The current Marketable Securities is ₹0 Mil. Indegene's overall GF Score™ is 50/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Indegene (NSE:INDGN), the current Marketable Securities is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Indegene Business Description

Other Exchanges 544172:India
Address Outer Ring Road, Aspen Block G4, 3rd Floor, Manyata Embassy Business Park, Nagawara, Bengaluru, KA, IND, 560045
Indegene Ltd provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech, and medical device companies. It assists them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products. Its portfolio of solutions covers all aspects of commercial, medical, regulatory, and R&D operations for life sciences companies. The company's segments include Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation, and Others. Key revenue is generated from the Omnichannel Activation segment. The company has a presence in India, Europe, and North America, with the majority of revenue coming from North America.
50GF Score

Get the complete analysis for NSE:INDGN

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹601.50
Price